| Valid Data Submission Method(s) | Measure Type | High Priority Measure? | NQS Domain | Specialty Measure Sets |
|---|---|---|---|---|
| Registry | Process | No | Community/Population Health | Obstetrics/Gynecology |
Measure Description
The percentage of female adolescents 16 years of age who had a chlamydia screening test with proper follow-up during the measurement period
Instruction
This measure is to be reported once per performance period for patients seen during the performance period. This measure may be reported by eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding.
Denominator
Sexually active female adolescents who turned 16 years of age during the measurement period with a visit during the measurement period and a visit in the year prior to the measurement period
DENOMINATOR NOTE: Evidence of sexual activity includes any of the following: -Documentation of sexual activity-Prescription for contraception-Treatment or Screening for sexually transmitted disease-Pregnancy- Pelvic examination
*Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician FeeSchedule (PFS). These non-covered services should be counted in the denominator population for registry-based measures.
Denominator Criteria (Eligible Cases):
Female Patients who turn 16 years of age during the measurement period
AND
Patient Encounter during the performance period (CPT): 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, 99384, 99385, 99394, 99395
AND
Patient Encounter during year prior to the performance period (CPT): 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, 99384*, 99385*, 99394*, 99395*
AND
Documentation of sexual activity: G9818
AND NOT
DENOMINATOR EXCLUSION:
Patients who use hospice services any time during the measurement period: G9819
Numerator
Adolescents who had documentation of a chlamydia screening test with proper follow-up during the measurement
period
Numerator Instructions: Documentation must include a note indicating the date and each of the following:
A chlamydia test result AND for abnormal or indeterminate results, evidence of confirmatory testing, referral
or treatment.
Numerator Options:
Performance Met: Documentation of a chlamydia screening test with proper follow-up (G9820)
OR
Performance Not Met: No documentation of a chlamydia screening test with proper follow-up (G9821)